GUILD 2020 Obesity Type Factors Into Weight Loss Success Obesity rates in the United States are projected to approach 50% by the year 2030, and matching the right patient to the most appropriate ...
GUCS 2020 Unprecedented Response Rate in Advanced Bladder Cancer The combination of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial cancer was called 'very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback